|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, October 18, 2021 )
Market Overview
Tobacco use can lead to tobacco/nicotine dependence and serious health problems. Quitting smoking greatly decreases the risk of developing smoking-related diseases. Tobacco/nicotine dependence is a condition that often requires repeated treatments, but there are helpful treatments and resources for quitting.
Tobacco smoke contains a deadly mix of more than 7,000 chemicals, of which hundreds are harmful, and about 70 can cause cancer. Smoking increases, therefore, increases the risk of serious health problems, many diseases, and death. People who stop smoking greatly reduce their risk of disease and early death.
View full report: https://www.datamintelligence.com/research-report/smoking-cessation-aids-market
Market Dynamics
The global smoking cessation aids market growth is driven by the rising addiction toward tobacco smoking, increasing number of campaigns to reduce smoking and tobacco dependence are some of the factors driving the market growth.
Rising awareness about smoking cessation therapy is expected to drive the market growth
Smoking is one of the major causes of lung cancer and other respiratory and cardiac diseases. Awareness about these health hazards has influenced individuals to adopt smoking cessation therapy. The awareness among the individuals is through digital media, print media, and other sources of information have proved to be effective in curbing the nicotine addiction crisis to some extent.
Cigarette smoking remains the leading cause of preventable disease, disability, and death. According to the Centers for Disease Control and Prevention (CDC), In 2019, nearly 14 of every 100 U.S. adults aged 18 years or older (14.0%) smoked cigarettes. This hints at a high usage of de-addiction products.
Also, this depicts the growing awareness of the people and their readiness to quit smoking. There are also non-government and government establishments are working to educate and help people quit smoking that is engaged dedicatedly to bring the number of smokers down.
For instance, in 2017, the U.S. Food and Drug Administration launched an adult smoking cessation education campaign to encourage cigarette smokers to quit smoking.
Market Segmentation
Global Smoking Cessation Aids Market – By Product
• Nicotine Replacement Therapy
o NRT Gum
o NRT lozenges
o NRT Inhalers
o NRT Patches
o Nicotine nasal sprays
• Medications
o Bupropion
o Varenicline
• Electronic Cigarettes
• Heat-not-burn Tobacco Products
• Others
Global Smoking Cessation Aids Market – By Distribution Channel
• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies
• Others
Global Smoking Cessation Aids Market - By Region
• North America
• Europe
• Asia-Pacific
• Middle East & Africa
• South America
Download free sample: https://www.datamintelligence.com/download-sample/smoking-cessation-aids-market
Competitive Landscape
The global smoking cessation aids market is highly competitive with the presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Takeda Pharmaceutical Company Limited, NJOY, Pfizer Inc, Cipla Ltd, GlaxoSmithKline Plc, Dr. Reddy's Laboratories, Juul Labs, Glenmark, Perrigo Company plc, Johnson and Johnson Services, Inc and Imperial Brands.
The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally. For instance, in July 2020, Dr. Reddy's Laboratories launched OTC Nicotine Polacrilex Lozenges in the United States. The Nicotine lozenges brands and store brand markets witnessed United States retail sales of about USD 200 million in 2020. The product is a significant addition to the company’s offering of Nicotine Replacement Therapy.
Topic's you may be interested, Dysthymia Drugs Market, Benzodiazepine Drugs Market, Chondroitin Sulfate Market, Artemisinin Combination Therapy Market, Tapentadol Market
DataM Intelligence
Sai Kiran
+1 877 441 4866
pr@datamintelligence.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
